Cardinal Health saw a double-digit hike in fiscal third quarter
revenues mirrored by a decline in operating earnings, as gains in
its drug distribution and medical products businesses were offset
by lower profits in sterile manufacturing...
Drug distribution and pharmaceutical technology firm Cardinal
Health has added detail to its previously announced restructuring
initiative with the news that it plans to cut 4,200 jobs and close
25 facilities around the world.
Singapore-based biologics contract manufacturer, A-Bio Pharma has
won its first contract after entering into a process development
and clinical supply service agreement with GlaxoSmithKline's
vaccine division, GlaxoSmithKline...
Cardinal Health reported its long-delayed fourth-quarter financial
results yesterday, revealing a hike in profit and revenues for the
three months to end June, but lowered guidance for the first half
of this fiscal year.